Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

83.89 +22.18 (+35.94%)
Official Closing Price Updated: 7:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Nasdaq Tumbles Over 100 Points; US Consumer Sentiment Falls In November
 
Via Benzinga
What's going on in today's session
Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Dropbox, Globus Medical, Expedia, Genpact And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
Why Globus Medical (GMED) Stock Is Trading Up Today
Shares of medical device company Globus Medical (NYSE:GMED) jumped 32.7% in the afternoon session after the company reported third-quarter results that significantly beat analyst estimates and raised... 
Via StockStory
Topics Economy Government World Trade
Earnings Scheduled For November 6, 2025
 
Via Benzinga
A Preview Of Globus Medical's Earnings
 
Via Benzinga
Keep an eye on the top gainers and losers in Friday's session.
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
These stocks are gapping in today's session
The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
GMED Q3 Deep Dive: U.S. Spine Momentum and Nevro Integration Drive Upbeat Results
Medical device company Globus Medical (NYSE:GMED) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 22.9% year on year to $769 million. The company’s full-year revenue guidance of... 
Via StockStory
Here's What Stimulated Global Medical's Third-Quarter Blowout
The company wrapped its acquisition of a spinal cord stimulating company earlier this year. 
Via Investor's Business Daily
This Expedia Group Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday
 
Via Benzinga
Discover the top movers in Friday's pre-market session.
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Globus Medical Inc (NYSE:GMED) Stock Surges on Strong Q3 2025 Earnings Beat and Raised Guidance
Globus Medical's Q3 2025 earnings crushed estimates, with EPS of $1.18 beating by 47%. The stock surged over 22% as the company also raised its full-year profit guidance. 
Via Chartmill
Topics Earnings
Globus Medical’s (NYSE:GMED) Q3: Strong Sales, Stock Jumps 19.2%
Medical device company Globus Medical (NYSE:GMED) announced better-than-expected revenue in Q3 CY2025, with sales up 22.9% year on year to $769 million. The company’s full-year revenue guidance of... 
Via StockStory
What's going on in today's after hours session
Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
Globus Medical Reports Third Quarter 2025 Results
From Globus Medical
Via GlobeNewswire
Globus Medical (GMED) Q3 Earnings: What To Expect
Medical device company Globus Medical (NYSE:GMED) will be reporting results this Thursday after market hours. Here’s what investors should know. 
Via StockStory
2 Growth Stocks with All-Star Potential and 1 We Find Risky
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who... 
Via StockStory
Topics Electric Vehicles
Paradice Dumped Its Entire $15.2 Million Progressive Software Stake
Paradice Dumped Its Entire $15.2 Million Progressive Software Stake 
Via The Motley Fool
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
From Globus Medical
Via GlobeNewswire
Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
Winners And Losers Of Q2: Globus Medical (NYSE:GMED) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including Globus Medical (NYSE:GMED) and its peers. 
Via StockStory
3 Cash-Producing Stocks Worth Your Attention
Businesses with strong free cash flow tend to be more adaptable and resilient. Some of these companies shine bright by using their cash wisely to strengthen their market positions. 
Via StockStory
1 Cash-Heavy Stock with Exciting Potential and 2 That Underwhelm
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining... 
Via StockStory
2 Reasons to Watch GMED and 1 to Stay Cautious
Globus Medical’s stock price has taken a beating over the past six months, shedding 21.5% of its value and falling to $57.60 per share. This may have investors wondering how to approach the situation. 
Via StockStory
Topics Government World Trade
Growth Titans: Eli Lilly's Weight-Loss Surge vs. Johnson & Johnson's Diversified Might
The pharmaceutical landscape is currently a tale of two giants employing vastly different, yet highly successful, growth strategies. Eli Lilly and Company (NYSE: LLY) has placed an extraordinary bet on... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
2 of Wall Street’s Favorite Stocks with Promising Prospects and 1 We Question
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.